Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 700 mg leronlimab
Total 0 results
Nothing found
Sponsors and Collaborators
AtheroNova Inc.
Virginia G. Kaklamani
LM Farma Indústria e Comércio Ltda.
BiondVax Pharmaceuticals ltd.
MITO
Camilla Wistrand
Eyal Ashkenazi
Nottingham University Hospitals NHS Trust
Ministère de la Santé et l'Hygiène Publique, Mali
OLVG, Amsterdam, the Netherlands
Yu-Hsiang Wu
GenVivo, Inc.
E. Steve Woodle
Vituity Psychiatry
Bruno Rhiner
Katarzyna Jórasz
Medical College Trivandrum
STAG1 Gene Foundation
Department of Emergency Medicine, The First People's Hospital of Hangzhou, Hangzhou, China.
Asahi Kasei Medical Co., Ltd.
View Full List
Medical Conditions
Alpha-Dystroglycanopathy (Dystroglycanopathy, Congenital With or Without Mental Retardation (Formerly MDC1C))
Phenoxymethylpenicillin
Mast-Cell Sarcoma
Serum Bank
Cervical Cancer Stage IA2
Patients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)
Rotator Cuff Lesion
Child Physical Activity
Imaging, Diagnostic
Soft Tissue Sarcoma, Adult, Stage II
Autism or Autistic Traits
Synbiotics
Learning Disturbance
Intensive Care Neuropathy
Stage IVA Lymphoepithelioma of the Oropharynx
Any Injury or Illness Acutely Impacting Work
HPV-Related Anal Intraepithelial Neoplasia
Nondepolarising Muscle Relaxants
NR3C2
Symptoms
View Full List
Drug Interventions
Miglustat
Lidocaine/ ketamine
LDEPA
Exendin 9-39
Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
5-Fluorouracil
Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
Transdermal estradiol
FHND5071
Dexmedetomidine
Interleukin-2
CD25 treatment
Apremilast
Methotrexate
Insulin
Extended release guanfacine
Ozanimod
Interferon beta-1b (Betaferon, BAY86-5046)
Thiotepa
Rituximab plus CHOP
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Bangladesh
Contract Research Organizations in Chile
Contract Research Organizations in Estonia
Contract Research Organizations in Gambia
Contract Research Organizations in Greece
Contract Research Organizations in Ireland
Contract Research Organizations in Latvia
Contract Research Organizations in Netherlands
Contract Research Organizations in Nigeria
Contract Research Organizations in Togo
Contract Research Organizations in Tunisia
Contract Research Organizations in Zambia
CRO list by country
CROs in Japan
NAMSA
Charles River Laboratories
Lonza
MakroCare
SGS
Aris Global
Fountain Medical Development (FMD)
Parexel
A2 Healthcare Corporation
Biotoxtech CRO
All CROs in Japan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe